Answers are grounded in this paper and cite their sources.
The role of the pharmacist in cancer care has continued to evolve over the last 50 years, in part due to more consistent integration of the pharmacist into cancer care teams. There has been tremendous growth in the number of practitioners who practice as oncology pharmacists since the inception of oncology pharmacy as a distinct practice specialty, with 1626 having earned the Board Certified Oncology Pharmacist (BCOP) designation as of 2014.1 Not surprisingly, the growth of the specialty has resulted in the expansion of training programs. Currently, there are 85 ASHP-accredited oncology specialty residency programs, accounting for 133 residency positions in 2015.2 Today the scope of oncology pharmacy practice is diverse. A clinical oncology pharmacist may focus on oncology pharmacy operations or patient care—often, the integration of both. The practice environment of oncology pharmacy has also expanded from a predominantly inpatient base to include practice in a variety of ambulatory care settings. Furthermore, with the ongoing need to develop better and more effective drug therapy for cancer, there is a need for a significant pharmacist presence in the area of investigational drug services. In addition to establishing a strong clinical and operational presence, oncology pharmacists have assumed leadership roles in healthcare settings such as hospitals, health systems, and clinics and in the area of home infusion services. Their roles can expand beyond direct patient care into academia, the pharmaceutical industry, and managed care and payer organizations, as well as areas such as research and informatics and clinical decision support. Oncology pharmacists have continued to develop innovative roles to best support individuals with cancer and their caregivers and to advance healthcare overall. A recent perspective on the role of the oncology pharmacist in healthcare delivery noted that the oncology pharmacist today represents a range of experiences and levels of practice, skills, and responsibilities.3 This diverse scope of practice has fueled continued demand for oncology-trained pharmacists to provide optimal care to patients with various malignant diseases and to help manage the complications and challenges of cancer.
No takes yet. Share an insight, caveat, or question.
Shank et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: